4.52
+1.12%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Journey Medical
From its filings with the US Securities and Exchange Commission
Journey Medical is based in Scottsdale, Arizona and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker DERM. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $61.9m and a net loss of $11.4m. At that date it held total assets of $94.6m and shareholders' equity of $31.9m.
We are a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions. Our current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. We acquire rights to products and product candidates by licensing or otherwise acquiring an ownership interest in, funding the research and development of, and eventually commercializing the products through our field sales organization. We are a controlled subsidiary of Fortress Biotech, Inc. (“Fortress” or “Parent”).
On November 1, 2024, the FDA approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed by Journey in collaboration with Dr. Reddy’s Laboratories, Ltd. (“DRL”). Our initial supply became available in March 2025. We began sales promotion of Emrosi beginning in April 2025, and we are commercializing Emrosi in the U.S. with our existing commercial team.
Effective after the close of U.S. equity markets on June 27, 2025, we joined the small cap Russell 2000® Index and the broad-market Russell 3000® Index as a result of the 2025 annual Russell Index reconstitution.
Quoted from its 10-K, filed 26 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 12 Nov 2021
- Employees
- 58
- Website
- journeymedicalcorp.com ↗
- Head office
- 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
- Incorporated in
- DE
- Classification
- Pharmaceutical Preparations
- Filer status
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Leadership
Pay as last reported
- Dr. Lindsay RosenwaldExecutive Chairman of the Board, since 2014$100,000
- Mr. Claude MaraouiPresident, Chief Executive Officer, Director, since 2021$2.6m
- Mr. Joseph BeneschChief Financial Officer, Corporate Controller$1.2m
- Mr. Ramsey AlloushChief Operating Officer, General Counsel, since 2025
- Mr. Neil HerskowitzIndependent Director$110,000
- Mr. Michael PearceIndependent Director$187,713
- Mr. Justin SmithIndependent Director$100,000
- Ms. Miranda ToledanoIndependent Director$100,000
- Ms. Jaclyn JaffeInvestor Relations, since 2021
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Journey Medical Corp has a strong market presence and brand recognition in the medical industry.
- The company possesses a diverse product portfolio, offering a wide range of medical solutions.
- Journey Medical Corp has a robust distribution network, allowing for efficient product delivery.
- The company benefits from a highly skilled and experienced management team.
Weaknesses
- Journey Medical Corp may face challenges in adapting to rapidly changing market trends.
- The company's heavy reliance on a few key suppliers could lead to supply chain vulnerabilities.
- Journey Medical Corp might have limited financial resources for significant research and development initiatives.
Opportunities
- The growing demand for medical products presents an opportunity for Journey Medical Corp to expand its market share.
- Advancements in technology offer the potential for innovative medical solutions and treatments.
- Journey Medical Corp can explore strategic partnerships to enhance its product offerings and enter new markets.
Threats
- Intense market competition could erode Journey Medical Corp's market share and profitability.
- Regulatory changes and compliance requirements may pose challenges for the company.
- Economic instability or recessions could impact consumer spending on medical products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.